Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr 18:14:1185678.
doi: 10.3389/fpsyt.2023.1185678. eCollection 2023.

Editorial: Assessing the consequences of antidepressant treatments

Markus Kosel  1 , Chong Guang Ng  2 , Norio Yasui-Furukori  3
Affiliations
Editorial

Editorial: Assessing the consequences of antidepressant treatments

Markus Kosel et al. Front Psychiatry. .
No abstract available

Keywords: citalopram; drug therapy; emotion regulation; lithium; major depressive disorder; menstrual bleeding; psychedelic agents.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Assessing the consequences of antidepressant treatments

References

    1. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. . Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. (2000) 47:351–4. 10.1016/S0006-3223(99)00230-9 - DOI - PubMed
    1. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. . A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. (2006) 63:856–64. 10.1001/archpsyc.63.8.856 - DOI - PubMed
    1. Marwaha S, Palmer E, Suppes T, Cons E, Young AH, Upthegrove R. Novel and emerging treatments for major depression. Lancet. (2023) 401:141–53. 10.1016/S0140-6736(22)02080-3 - DOI - PubMed
    1. Jollant F, Colle R, Nguyen TML, Corruble E, Gardier AM, Walter M, et al. . Ketamine and esketamine in suicidal thoughts and behaviors: A systematic review. Ther Adv Psychopharmacol. (2023) 13:20451253231151327. 10.1177/20451253231151327 - DOI - PMC - PubMed
    1. Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, et al. . The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force report: Serotonergic psychedelic treatments for major depressive disorder. Can J Psychiatry. (2023) 68:5–21. 10.1177/07067437221111371 - DOI - PMC - PubMed

Publication types

LinkOut - more resources